发明名称 DUPA-INDENOISOQUINOLINE CONJUGATES
摘要 A targeting ligand-cytotoxic drug conjugate, for example, a DUPA-Indenoisoquinoline conjugate, is useful for treating cancers, e.g., prostate cancer.
申请公布号 US2016367685(A1) 申请公布日期 2016.12.22
申请号 US201415035157 申请日期 2014.11.05
申请人 PURDUE RESEARCH FOUNDATION 发明人 Cushman Mark S.;Low Phillip S.;Nguyen Trung X.
分类号 A61K47/48;A61K31/473 主分类号 A61K47/48
代理机构 代理人
主权项 1. A DUPA-Indenoisoquinoline conjugate represented by formula (IB) DUPA-Linker-RS-Indenoisoquinoline  (IB)wherein DUPA is a modified or unmodified 2-[3-(1,3-dicarboxypropyl)-ureido]pentanedioic acid; Linker is a bond, a substituted or unsubstituted alkyl, a peptide, or a peptidoglycan; Indenoisoquinoline is a substituted or unsubstituted indenoisoquinoline; and RS is a release segment capable of releasing Indenoisoquinoline within the desired cells,wherein said release segment is a carbonate segment, a carbamate segment, or an acylhydrazone segment.
地址 West Lafayette IN US
您可能感兴趣的专利